Rediscovering plant-based drugs [2]

Nature Biotechnology

Volumn 21, Issue 8, 2003, Pages 843-844

  Littleton, John ^a   Falcone, Deane ^a   Davies, H Maelor ^b  

^a Naprogenix   (United States)

^b Kentucky Tobacco Research and Development Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL PRODUCT; NEW DRUG;

DRUG INDUSTRY; DRUG RESEARCH; GENOMICS; LETTER; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SCREENING;

EID: 0043208926     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0803-843b     Document Type: Letter

References (5)

1. Demain, A. Nat. Biotechnol. 20, 331 (2002).
2. Abelson, P.H. Science 279, 2019 (1998).
3. The Arabidopsis Genome Initiative. Nature 408, 796-815 (2000).
4. Poulev, A. et al. J. Med. Chem. 46, 2542-2547 (2003).
5. Dixon, R.A. & Paiva, N.L. Plant Cell 7, 1085-1097 (1995).